Neovascular Clinical Trial
— PFCOfficial title:
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy in a Single Session Using Low Fluence Parameters
| NCT number | NCT01023698 |
| Other study ID # | APEC0003 |
| Secondary ID | |
| Status | Terminated |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | April 2009 |
| Est. completion date | April 2010 |
| Verified date | May 2024 |
| Source | Asociación para Evitar la Ceguera en México |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Is it possible to do a panretinal photocoagulation for proliferative diabetic retinopathy in a single session using low fluence parameters?
| Status | Terminated |
| Enrollment | 30 |
| Est. completion date | April 2010 |
| Est. primary completion date | April 2010 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 70 Years |
| Eligibility | Inclusion Criteria: - untreated Proliferative diabetic retinopathy Exclusion Criteria: - Previous photocoagulation |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Asociación para Evitar la Ceguera en México |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Stabilization of proliferative diabetic retinopathy | 2010 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00384631 -
Intravitreal Bevacizumab for Neovascular Glaucoma
|
N/A |